![]() |
市場調査レポート
商品コード
1530698
代替タンパク質の2030年までの市場予測:由来、形態、生産プロセス、流通チャネル、用途、地域別の世界分析Protein Alternatives Market Forecasts to 2030 - Global Analysis By Source, Form, Production Process, Distribution Channel, Application and By Geography |
||||||
カスタマイズ可能
|
代替タンパク質の2030年までの市場予測:由来、形態、生産プロセス、流通チャネル、用途、地域別の世界分析 |
出版日: 2024年08月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、世界の代替タンパク質市場は2024年に275億5,000万米ドルを占め、予測期間中のCAGRは18.4%で成長し、2030年には759億1,000万米ドルに達する見込みです。
代替タンパク質質とは、従来の動物性蛋白質の代替または補完となる非伝統的な蛋白源です。これらの代替タンパク質質は通常、植物、菌類、あるいは培養動物組織由来であり、持続可能で倫理的な、あるいは健康に関連した食生活を求める個人に多様な選択肢を提供しています。大豆、レンズ豆、キヌアなどの植物性タンパク質は、その完全なアミノ酸プロファイルと高い栄養価により、顕著な例です。
国連食糧農業機関によると、2050年までに穀物の需要は、現在の21億トン近くから、食用・飼料用ともに30億トン前後に増加すると予想されています。
菜食主義者とベジタリアン人口の増加
菜食主義者とベジタリアン人口の増加は、代替タンパク質の需要と技術革新を促進し、食品業界の情勢を再構築しています。健康上、環境上、倫理上の理由から植物ベースの食生活を採用する人が増えるにつれて、従来の動物性食品以外の蛋白源に対するニーズが高まっています。この変化は、大豆、エンドウ豆、ひよこ豆、麻などの植物性タンパク質の急増に拍車をかけています。代替タンパク質の増加は、菜食主義者やベジタリアンの嗜好を満たすだけでなく、より健康的で持続可能な食品を求める幅広い層にアピールしています。
規制上のハードル
代替タンパク質市場は、イノベーションと市場参入の障壁となる規制上のハードルによる大きな課題に直面しています。食品の安全性、ラベリング、成分承認に関する規制は世界的に異なっており、代替タンパク質製品の開発と流通を複雑にしています。地域によっては、新しい原料や製造方法に対する厳しい要件が製品の発売を遅らせ、メーカーのコストを増大させることもあります。植物由来」、「ラボ栽培」、「培養」といった用語の定義や基準が異なることが、規制遵守や消費者の理解をさらに複雑にしています。
代替タンパク質への需要の高まり
代替タンパク質に対する需要の高まりは、世界の食品業界における変革的な変化を意味します。この動向は、環境問題、健康への配慮、倫理的動機など、いくつかの要因によって推進されています。代替タンパク質には、植物性タンパク質(大豆、エンドウ豆、レンズ豆など)、培養タンパク質(細胞農業で生産)、新規の供給源(藻類や昆虫など)など、多様な供給源が含まれます。さらに、持続可能性、環境負荷の低さ、従来の動物性タンパク質に匹敵する栄養価の高さなどから、これらの代替タンパク質を選ぶ消費者も増えています。
微生物リスクとアレルギー反応
微生物リスクは、発酵や培養方法など、これらの代替食品を製造する際の製造工程から生じるもので、厳密に管理されなければ汚染につながる可能性があります。この懸念は、食品の安全性と品質基準に対する消費者の期待によって増幅されます。一般的な植物性タンパク質(大豆、ナッツなど)や代替タンパク質製品に使用されるその他の成分に対するアレルギーを持つ人が副作用を経験する可能性があるため、アレルギー反応も重大なハードルとなります。こうした問題は、消費者の信頼や規制当局の監視に影響を与えることで市場成長の妨げとなるため、業界各社はこうしたリスクを軽減するための研究開発や厳しい品質管理対策に多額の投資を行う必要に迫られています。
COVID-19パンデミックは代替タンパク質市場に大きな影響を与えました。危機が展開する中、サプライチェーンや製造業の混乱は、食肉などの伝統的なタンパク源の生産と流通に課題をもたらしました。このため、サプライチェーンの混乱に強く、健康面や持続可能性でもメリットがあるとされる植物性タンパク質のような代替タンパク源に対する消費者の関心と需要が高まった。しかし、パンデミックは人獣共通感染症に対する懸念を浮き彫りにし、より安全な代替品として植物性タンパク質やその他の非伝統的なタンパク質源に対する関心をさらに高めました。
藻類タンパク質セグメントは予測期間中最大になる見込み
藻類タンパク質セグメントは、大豆や乳清のような伝統的なタンパク質源に代わる持続可能で栄養価の高い代替品を提供することで、予測期間中に最大となる見込みです。藻類、特にスピルリナやクロレラなどの微細藻類は、必須アミノ酸、ビタミン、ミネラルが豊富で、栄養価が高いです。藻の栽培は、従来の作物に比べて土地と淡水が最小限で済むため、環境にやさしく、拡張性があります。藻類タンパク質は大豆や乳製品によく含まれるアレルゲンを含まないため、この技術革新は植物性食生活や菜食主義を求める消費者にアピールします。
専門店セグメントは予測期間中最も高いCAGRが見込まれる
専門店セグメントは、健康志向の消費者の嗜好に合わせた多様で革新的な製品を提供することで、予測期間中に最も高いCAGRが見込まれます。これらの店舗は、特に植物性タンパク質に対する需要の高まりに対応し、豆腐、テンペ、セイタン、各種豆類ベースの製品などの代替品を提供しています。従来のスーパーマーケットとは異なり、専門店ではビーガン、ベジタリアン、フレキシタリアン向けの高品質でニッチな商品を厳選して提供することが多いです。さらに、教育や探求の拠点としての役割も果たし、新しいタンパク源や環境責任を促進する持続可能な食品の選択肢を紹介しています。
畜産に関連する健康と持続可能性への懸念に対する意識の高まりと、ベジタリアンやフレキシタリアン食を採用する消費者の増加により、推定期間中、欧州地域が市場の最大シェアを占めました。植物性タンパク質は、従来の動物性タンパク質に代わる実行可能な選択肢を提供し、多様な食生活の嗜好やライフスタイルに対応します。さらに、食品技術の革新により、肉や乳製品の味、食感、栄養プロファイルを模倣した植物性製品が開発され、この地域の成長をさらに加速させています。
欧州地域は、予測期間中に大幅な成長を遂げると推定されます。持続可能性、健康、動物福祉を目的とした厳しい規制が、食品メーカーにこの地域全体で製品の革新と多様化を促しています。植物ベースの食生活を推進し、食肉消費を削減し、持続可能な農業慣行を育成する政策は、植物ベースのタンパク質、藻類ベースのタンパク質、培養肉などの代替タンパク質の拡大を促す環境をこの地域全体に生み出しています。その結果、欧州は代替タンパク質のハブとして台頭し、より持続可能で健康的な食品選択へのシフトを促進しながら、投資を誘致し市場の成長を牽引しています。
According to Stratistics MRC, the Global Protein Alternatives Market is accounted for $27.55 billion in 2024 and is expected to reach $75.91 billion by 2030 growing at a CAGR of 18.4% during the forecast period. Protein alternatives refer to non-traditional sources of protein that can substitute or complement conventional animal-based proteins. These alternatives are typically derived from plants, fungi, or even cultivated animal tissues, offering diverse options for individuals seeking sustainable, ethical, or health-related dietary choices. Plant-based proteins, such as soybeans, lentils, and quinoa, are prominent examples due to their complete amino acid profiles and high nutritional value.
According to the Food and Agriculture Organization, by 2050, the demand for cereals is expected to increase from its current level of close to 2.1 billion tons to around 3 billion tons for both food and animal feed.
Increasing vegan and vegetarian population
The increasing vegan and vegetarian population is driving the demand and innovation in protein alternatives, reshaping the food industry landscape. As more people adopt plant-based diets for health, environmental, and ethical reasons, there's a growing need for protein sources beyond traditional animal products. This shift has spurred a surge in plant-based protein options such as soy, pea, chickpea, and hemp, which are not only rich in protein but also offer diverse nutritional benefits. The rise in protein alternatives is not only meeting the dietary preferences of vegans and vegetarians but also appealing to a broader audience seeking healthier and sustainable food options.
Regulatory hurdles
The Protein Alternatives Market faces significant challenges due to regulatory hurdles, which pose barriers to innovation and market entry. Regulations governing food safety, labeling, and ingredient approval vary globally, complicating the development and distribution of alternative protein products. In some regions, stringent requirements for new ingredients or production methods can delay product launches and increase costs for manufacturers. Differing definitions and standards for terms like "plant-based," "lab-grown," or "cultivated" further complicate regulatory compliance and consumer understanding.
Rising demand for alternate protein
The rising demand for alternative proteins signifies a transformative shift in the global food industry. This trend is driven by several factors, including environmental concerns, health considerations, and ethical motivations. Alternative proteins encompass a diverse range of sources such as plant-based proteins (like soy, pea, and lentils), cultured proteins (produced through cellular agriculture), and novel sources (such as algae or insects). Furthermore, consumers are increasingly opting for these alternatives due to their perceived sustainability, lower environmental impact, and nutritional benefits comparable to traditional animal-based proteins.
Microbial risk and allergic reactions
Microbial risks arise from the production processes involved in creating these alternatives, such as fermentation or cultivation methods, which may lead to contamination if not rigorously controlled. This concern is amplified by consumer expectations for food safety and quality standards. Allergic reactions pose another significant hurdle, as individuals with allergies to common plant-based proteins (e.g., soy, nuts) or other ingredients used in alternative protein products may experience adverse effects. These issues hinder market growth by affecting consumer confidence and regulatory scrutiny, prompting industry players to invest heavily in research, development, and stringent quality control measures to mitigate these risks.
The COVID-19 pandemic significantly influenced the protein alternatives market. As the crisis unfolded, disruptions in supply chains and manufacturing posed challenges to the production and distribution of traditional protein sources such as meat. This led to increased consumer interest and demand for alternative protein options like plant-based proteins, which were perceived as more resilient to supply chain disruptions and were also associated with health and sustainability benefits. However, the pandemic highlighted concerns over zoonotic diseases, further driving interest in plant-based and other non-traditional protein sources as safer alternatives.
The Algae Protein segment is expected to be the largest during the forecast period
Algae Protein segment is expected to be the largest during the forecast period by offering a sustainable and nutritious alternative to traditional protein sources like soy and whey. Algae, particularly microalgae such as spirulina and chlorella, are rich in essential amino acids, vitamins, and minerals, making them highly nutritious. Algae cultivation requires minimal land and freshwater compared to traditional crops, making it environmentally friendly and scalable. This innovation appeals to consumers seeking plant-based or vegan diets, as algae proteins are free from allergens commonly found in soy and dairy products.
The Specialty Store segment is expected to have the highest CAGR during the forecast period
Specialty Store segment is expected to have the highest CAGR during the forecast period by offering a diverse range of innovative products tailored to the preferences of health-conscious consumers. These stores cater specifically to the growing demand for plant-based proteins, offering alternatives such as tofu, tempeh, seitan, and various legume-based products. Unlike conventional supermarkets, Specialty Stores often provide a curated selection of high-quality, niche products that appeal to vegan, vegetarian, and flexitarian diets. Furthermore, they serve as hubs for education and exploration, showcasing new protein sources and sustainable food options that promote environmental responsibility.
Europe region dominated the largest share of the market during the extrapolated period, due to rising awareness of health and sustainability concerns associated with animal farming, coupled with a growing number of consumers adopting vegetarian or flexitarian diets. Plant-based proteins offer a viable alternative to traditional animal-derived proteins, catering to diverse dietary preferences and lifestyles. Furthermore, innovations in food technology have led to the development of plant-based products that mimic the taste, texture, and nutritional profile of meat and dairy products, further accelerating regional growth.
Europe region is estimated to witness substantial growth over the projection period. Stringent regulations aimed at sustainability, health and animal welfare are compelling food manufacturers to innovate and diversify their product offerings across the region. Policies promoting plant-based diets, reducing meat consumption, and fostering sustainable agricultural practices are creating a conducive environment for the expansion of protein alternatives such as plant-based proteins, algae-based proteins and cultured meat throughout the region. As a result, Europe is emerging as a hub for protein alternatives, attracting investments and driving market growth while promoting a shift towards more sustainable and healthy food choices.
Key players in the market
Some of the key players in Protein Alternatives market include Archer Daniels Midland Company, Aspire Food Group, Axiom Foods Inc, Bluebiotech International GmbH, Burcon Nutrascience Corporation, Calysta, Inc, Cargill, Incorporated, Cellena Inc, Glanbia PLC, JR Unique Foods Ltd, Kerry Group Plc and Plantible Foods, Inc.
In February 2024, Roquette expanded its Nutralys plant protein line by launching four new pea protein products, encompassing isolates, hydrolysates, and textured variants. These versatile pea proteins are designed to address formulation challenges in plant-based foods and high-protein nutritional products. They pave the way for innovation in various items, including nutritional bars, protein beverages, and plant-based meat and dairy alternatives.
In May 2023, ADM and Air Protein established a Strategic Development Agreement (SDA) to jointly develop innovative protein sources for nutrition. Air Protein produces protein through air-based techniques that bypass traditional agriculture and farmland, mitigating supply chain risks. This collaboration combines ADM's expertise in nutrition, formulation, and research with Air Protein's pioneering landless agriculture platform to enhance cost-effective protein ingredients for North American meat substitutes.
In June 2022, AMCO Proteins (US) acquired a 40,000-square-foot facility in Mountain Top, Pennsylvania, which includes five food-grade production rooms and storage space for over 500 pallets. This new facility is anticipated to boost and expand the company's spray drying, blending, and milling operations, thereby enhancing its business capabilities in these areas.
In April 2022, ADM made a strategic investment of USD 300 million to enhance alternative protein production at its Decatur, Illinois plant, aiming to double the facility's soy extrusion capacity. This investment also includes the construction of a Protein Innovation Center, equipped with labs, test kitchens, and pilot-scale production facilities, to strengthen the company's R&D capabilities.